Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             139 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A Challenging Case of Central Nervous System (CNS) Involvement with Chronic Lymphocytic Leukaemia (CLL): A Case Report Alshamali, Sara Ali

59 C p.
artikel
2 A Child with Intractable Vomiting: Brainstem Mass or Neuromyelitis Optica Spectrum Disorder Mehdipour, Roshanak

59 C p.
artikel
3 A comprehensive review of varicella-zoster virus, herpes simplex virus and cryptococcal infections associated with sphingosine-1-phosphate receptor modulators in multiple sclerosis patients Sharma, Kanika

59 C p.
artikel
4 Adrenoleukodystrophy in Adults: About a Case Hakim, Si Ahmed

59 C p.
artikel
5 Analysis of Visual Acuity, Contrast Sensitivity and Color Perception in Multiple Sclerosis Patients Oreja-Guevara, Celia

59 C p.
artikel
6 A national, multi-center study in Germany to assess implementation of infusion management, treatment satisfaction and quality of life in MS patients receiving alemtuzumab Räuber, Saskia

59 C p.
artikel
7 A Nationwide Pharmaco Epidemiological Study of Multiple Sclerosis in Greece Bakirtzis, Christos

59 C p.
artikel
8 An exploratory study regarding communication facilitators and barriers reported by a cohort of multiple sclerosis (MS) community members from the international massive open online course ‘Understanding MS’ Campbell, Julie A.

59 C p.
artikel
9 A novel disease specific scale to characterize the symptoms and impacts of fatigue in US adults with relapsing multiple sclerosis: A real-world study Azoulai, Marion

59 C p.
artikel
10 Anti-Inflammatory Compounds Ameliorate Locomotion and Anxiety Behaviors in Cuprizone Mouse Model of Multiple Sclerosis Alderbi, Rasha Mohammed

59 C p.
artikel
11 Anxiety in Patients with Multiple Sclerosis Bader, Sondes

59 C p.
artikel
12 Artificial intelligence in the diagnosis of multiple sclerosis: A systematic review Nabizadeh, Fardin

59 C p.
artikel
13 Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patients Saraste, Maija

59 C p.
artikel
14 Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study Sedaghat, Nahad

59 C p.
artikel
15 Association of Multiple Sclerosis and COVID-19 Infection: A Case Report Ismail, Ismail Ibrahim

59 C p.
artikel
16 Association of personality traits with physical function, cognition, and mood in multiple sclerosis Kever, Anne

59 C p.
artikel
17 Challenges of MS Patients for Receiving Health Care Services Eskandarieh, Sharareh

59 C p.
artikel
18 Chitinase-3 Like-Protein-1 in CSF: A Novel Biomarker for Progression in Multiple Sclerosis Patients Dahshan, Ahmed

59 C p.
artikel
19 Claims-Based Relapse and Hospitalization Rates in Patients with Multiple Sclerosis Treated with Natalizumab or Ocrelizumab Nicholas, Jacqueline

59 C p.
artikel
20 Clinical Characteristics of Switching Between Disease Modifying Drugs Among a Sample of Egyptian Multiple Sclerosis Patients Eissa, Asmaa

59 C p.
artikel
21 Clinical characteristics, sero- prevalence, treatment and outcomes of AQP4 IgG associated neuromyelits optic spectrum disorder (NMOSD) in Sri Lanka Senanayake, Bimsara

59 C p.
artikel
22 Clinical, Evolutionary and Etiological Particularities of Inflammatory Optic Neuropathies: An Algerian Population Islam, Kediha Mohamed

59 C p.
artikel
23 Cognitive Dual Tasking Impacts Lower Limbs Inter-Segmental Coordination During Walking in Patients with Multiple Sclerosis Mofateh, Razieh

59 C p.
artikel
24 Cognitive function in pediatric-onset relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) Fabri, Tracy L

59 C p.
artikel
25 Cognitive Impairment in Neuromyelitis Optica Spectrum Disorder and Brain Parenchyma Volume by Transcranial Sonography Magdy, Rehab

59 C p.
artikel
26 Comorbidity in multiple sclerosis: Emphasis on patient-reported outcomes Diržiuvienė, Birutė

59 C p.
artikel
27 Comparison of Time to Clinically Meaningful Improvement in Neuro-QOL in Patients Treated with Natalizumab Versus Ocrelizumab Hersh, Carrie M.

59 C p.
artikel
28 Contribution of relapse-associated worsening to overall disability accrual in patients with relapsing-onset multiple sclerosis: A mediation analysis Chen, Bo

59 C p.
artikel
29 COVID19 in Multiple Sclerosis Patients in Dubai: Observational Study Thakre, Mona

59 C p.
artikel
30 COVID-19 Vaccination in People with Multiple Sclerosis. the Kuwait Experience Alroughani, Raed

59 C p.
artikel
31 Demographic and Clinical Characteristics of Patients with Benign MS in Compare with Non-Benign MS Moghadam, Nahid Beladi

59 C p.
artikel
32 Demographic and Clinical Characteristics of Progressive Multiple Sclerosis: Findings from a Tunisian Cohort Study Mrabet, Saloua

59 C p.
artikel
33 Depression, Anxiety and Alexithymia in Tunisian Patients with Multiple Sclerosis Mrabet, Saloua

59 C p.
artikel
34 Depression in Multiple Sclerosis Bader, Sondes

59 C p.
artikel
35 Dialectical behavior therapy skills training for individuals with multiple sclerosis and their support partners: A pilot randomized controlled trial Hughes, Abbey J.

59 C p.
artikel
36 Distribution and relation of two arm function tests, Box and Blocks test and Nine Hole Peg test, across disease severity levels and types of multiple sclerosis Bertoni, Rita

59 C p.
artikel
37 Does Multiple Sclerosis Change Lower Limbs Inter-Segmental Coordination During Walking? Mofateh, Razieh

59 C p.
artikel
38 Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis Sainz de la Maza, Susana

59 C p.
artikel
39 Economic Analysis for Introduction of Cladribine Tablets as a Treatment for Relapsing Multiple Sclerosis Patients with High Disease Activity in Kuwait Alroughani, Raed

59 C p.
artikel
40 Effect of different initial rituximab regimens on B cell depletion in children with autoimmune neurological diseases Zhang, Enyao

59 C p.
artikel
41 Effects of Cognitive and Motor Secondary Tasks on Gait Performance in Healthy Controls and Multiple Sclerosis Patients with and Without Fall History Mofateh, Razieh

59 C p.
artikel
42 Effects of repetitive transcranial magnetic stimulation in multiple sclerosis: A systematic review and meta-analysis Chen, Xiao

59 C p.
artikel
43 Emotional processing intervention (EMOPRINT): A blinded randomized control trial to treat facial affect recognition deficits in multiple sclerosis Genova, Helen M.

59 C p.
artikel
44 Epidemiology of COVID-19 in Patients with MS: A Hospital-Based Registry Eskandarieh, Sharareh

59 C p.
artikel
45 Epidemiology of Multiple Sclerosis in Iraq: Retrospective Review of 4355 Cases and Literature Review Hassoun, Hayder K

59 C p.
artikel
46 Epidemiology of multiple sclerosis in West bank of Palestine Abuawad, M.

59 C p.
artikel
47 Evaluation of Anti-JVC Antibody Index Evolution in Patients with Multiple Sclerosis Atrous, Amal

59 C p.
artikel
48 Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets Yamout, Bassem I

59 C p.
artikel
49 Extended B-cell depletion beyond 6-months in patients receiving ocrelizumab or rituximab for CNS demyelinating disease AbdelRazek, Mahmoud A.

59 C p.
artikel
50 Familial MS in the South Caspian Sea Baghbanian, Seyedmohammad

59 C p.
artikel
51 First Study in Iraq About (HLA)-Drb1 * 15:01 as a Genetic Risk Factor for MS Initiation Khaliel, Alaa Hassan

59 C p.
artikel
52 Gender Based Epidemiologic Survey of Multiple Sclerosis Patients, a Report from Isfahan Province, Iran. Dastjerdi, Roshanak Mehdipour

59 C p.
artikel
53 Health-related quality of life in neuromyelitis optica spectrum disorder patients in an Argentinean cohort Carnero Contentti, Edgar

59 C p.
artikel
54 High or increasing serum NfL is predictive of impending multiple sclerosis relapses Thebault, Simon

59 C p.
artikel
55 Humoral and cellular immune responses to SARS CoV-2 vaccination in People with Multiple Sclerosis and NMOSD patients receiving immunomodulatory treatments Bock, H.

59 C p.
artikel
56 Humoral and cellular immunity in convalescent and vaccinated COVID-19 people with multiple sclerosis: Effects of disease modifying therapies Habek, Mario

59 C p.
artikel
57 Humoral Immune Response to SARS-CoV-2 Vaccination in MS Patients Oreja-Guevara, Celia

59 C p.
artikel
58 Hypogonadism in men with multiple sclerosis: Prevalence and clinical associations Diaconu, Claudiu

59 C p.
artikel
59 Identification of miRNAs and their potential effects on multiple sclerosis related pathways using ın silico analysis Erkal, Burcin

59 C p.
artikel
60 Identification of multiple sclerosis-related genes regulated by EBV-encoded microRNAs in B cells Rang, Xinming

59 C p.
artikel
61 Impact of Gender on Multiple Sclerosis Natural History: Findings from a Tunisian Cohort Kacem, Imen

59 C p.
artikel
62 Implications of Low-Titer MOG Antibodies Levy, Michael

59 C p.
artikel
63 Improvement of gait and balance in patients with multiple sclerosis after multidisciplinary physical rehabilitation: Analysis of real-world data in Russia Stepanova, A.

59 C p.
artikel
64 Improvements in Quality of Life at 1 Year in Patients Treated with Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: An Interim Analysis of Clarify-MS Solari, Alessandra

59 C p.
artikel
65 Incidence of cancer in patients with multiple sclerosis (MS) who were treated with fingolimod: A systematic review and meta-analysis Askari, Mozhde

59 C p.
artikel
66 Incidence, prevalence, and characteristics of heart failure among patients with multiple sclerosis: A systematic review and meta-analysis Bagherieh, Sara

59 C p.
artikel
67 Incidence, Severity, Outcomes, and Risk Factors of COVID-19 in Multiple Sclerosis: An Observational Study in the Middle East Alroughani, Raed

59 C p.
artikel
68 Inform Interferon Beta Exposure in the 2nd and 3rd Trimester of Pregnancy: A Register-Based Drug Utilisation Study in Finland and Sweden Espin, Meritxell Sabidó

59 C p.
artikel
69 Initial Clinical and Neuroradiological Features at Presentation of Patients with Multiple Sclerosis: A Hospital-Based Experience from Oman Al-Asmi, Abdullah

59 C p.
artikel
70 Intranasal administration of fingolimod (FTY720) attenuates demyelination area in lysolecithin-induced demyelination model of rat optic chiasm Ghasemi-Kasman, Maryam

59 C p.
artikel
71 Irregular degree centrality in neuromyelitis optica spectrum disorder patients with optic neuritis: A resting-state functional magnetic resonance imaging study Wei, Ruili

59 C p.
artikel
72 Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic Hradilek, Pavel

59 C p.
artikel
73 Lennox-Gastaut Syndrome and MS: Is it a Coincidence? Megherbi, Lilia

59 C p.
artikel
74 Lifetime physical activity is associated with gut bacteria and brain health in people with multiple sclerosis: Focus on physical activity intensity Mokhtarzade, Motahare

59 C p.
artikel
75 Long-Term Efficacy for Patients Receiving Cladribine Tablets in CLARITY/CLARITY Extension: Primary Results from 9–15 Years of Follow-Up in the CLASSIC-MS Study Giovannoni, Gavin

59 C p.
artikel
76 Lower motor neuron involvement in patients with neuromyelitis optica spectrum disorders He, Mianwang

59 C p.
artikel
77 Low vitamin D levels do not predict risk of autoimmune disease following alemtuzumab treatment for multiple sclerosis Arnett, Simon

59 C p.
artikel
78 Managing neuropsychological impairment in multiple sclerosis – Controlled study on a standardized metacognitive intervention (MaTiMS) Pöttgen, Jana

59 C p.
artikel
79 Markers of Epstein-Barr virus and Human Herpesvirus-6 infection and multiple sclerosis clinical progression Tao, Chunrong

59 C p.
artikel
80 Medical cannabis use in Canadians with multiple sclerosis Santarossa, Talia M

59 C p.
artikel
81 Medication Adherence Among Patients with Multiple Sclerosis During the COVID-19 Pandemic: Perspective from the Near East Region Al-Naqshbandi, Murad

59 C p.
artikel
82 MicroRNA-484 and Apoptotic Protease Activating Factor-1 Gene in Relapsing Remitting Multiple Sclerosis: the Possible Interplay Elmazny, Alaa

59 C p.
artikel
83 MRI Findings in Late-Onset Multiple Sclerosis; a Systematic Review and Meta-Analysis Naseri, Amirreza

59 C p.
artikel
84 Multiple Sclerosis During Pregnancy: Data from the MS Clinic in Benghazi Medical Center Bennour, Anwaar Mukhtar

59 C p.
artikel
85 Multiple Sclerosis Performance Test (MSPT): Normative study of 428 healthy participants ages 18 to 89 Rao, Stephen M.

59 C p.
artikel
86 Multiple Sclerosis Specialized Nurses in Saudi Arabia: Challenge, and Opportunities Alarieh, Rola

59 C p.
artikel
87 Neurofilament Light Chains: A Reliable Biomarker of Disease Activity in MS Ashfaq, Ayesha

59 C p.
artikel
88 NMOSD: How Long to Treat Chakraborty, Rajarshi

59 C p.
artikel
89 Patient Reported Outcomes of New Brand-Generic Product of Teriflunomide in Patients with Relapsing-Remitting Multiple Sclerosis: Preliminary Analysis Abolfazli, Roya

59 C p.
artikel
90 Pediatric neuromyelitis optica spectrum disorders in Portugal: A multicentre retrospective study Martins, Cecília

59 C p.
artikel
91 Pelvic floor muscle training in multiple sclerosis patients with lower urinary tract dysfunction: A systematic review and meta-analysis Kajbafvala, Mehrnaz

59 C p.
artikel
92 Perceived stress in multiple sclerosis patients: Relationship with mood states and pain experience Khedr, Mahmoud A.

59 C p.
artikel
93 Phenotyping the Pediatric Demyelinating Events at the Multiple Sclerosis Center at the American University of Beirut Saab, Georges

59 C p.
artikel
94 Physical exercise may improve problem-solving skills and emotional intelligence in patients with relapsing-remitting multiple sclerosis: A cross-sectional study Tasci, Irem

59 C p.
artikel
95 Practical issues concerning the use of Magnetic Resonance Imaging in Multiple Sclerosis in Latin America: Discussion from 16 centres on behalf of the Foro Latam EM Study Group Ciampi, Ethel

59 C p.
artikel
96 Pregnancy outcomes following maternal or paternal exposure to teriflunomide in the Danish MS population Andersen, Johanna Balslev

59 C p.
artikel
97 Pregnancy Outcomes in Patients with Multiple Sclerosis Following Exposure to Ofatumumab Yamout, Bassem

59 C p.
artikel
98 Prevalence of MS in Tehran, Iran in 2020 and Its Forecast for the Next 10 Years Eskandarieh, Sharareh

59 C p.
artikel
99 Prevalence of Urinary Tract Symptoms in Patients with Multiple Sclerosis and Health Care Seeking Behavior: A Cross Sectional Study in Riyadh, Saudi Arabia. Harbi, Awad Al

59 C p.
artikel
100 Primary Results of NOVA: A Randomized Controlled Study of the Efficacy of 6 Week Dosing of Natalizumab Versus Continued 4-Week Treatment for Multiple Sclerosis Foley, John

59 C p.
artikel
101 Psychological impacts of COVID-19 pandemic on individuals living with multiple sclerosis: A rapid systematic review Zarghami, Amin

59 C p.
artikel
102 Psychotic Symptoms Revealing Multiple Sclerosis: Case Report Bader, Sondes

59 C p.
artikel
103 Radiologically Isolated Syndrome Conversion to Multiple Sclerosis Sabeti, Fatemeh

59 C p.
artikel
104 Real-world experience on the use of COVID-19 vaccination in patients with multiple sclerosis treated with Cladribine tablets in the Gulf region Inshasi, Jihad

59 C p.
artikel
105 Real-World Experience with Cladribine in the MSBase Registry Butzkueven, Helmut

59 C p.
artikel
106 Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications – A pilot study Moser, Tobias

59 C p.
artikel
107 Regional (but strategic) assessment for a generalized disorder (Sarcopenia) Razaq, Sarah

59 C p.
artikel
108 Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis Ciampi, Ethel

59 C p.
artikel
109 Self-perceived versus physician documented adverse events in patients with multiple sclerosis REGIMS-a pharmacovigilance registry for patients with multiple sclerosis in Germany Moeller, Sarah Noelle

59 C p.
artikel
110 Serum molecular biomarkers in neuromyelitis optica and multiple sclerosis Fu, Cong-Cong

59 C p.
artikel
111 Serum Neurofilament Light Chain as a Biomarker in Multiple Sclerosis Hassoun, Hayder K.

59 C p.
artikel
112 Sleep Disorders in Multiple Sclerosis Patients Bader, Sondes

59 C p.
artikel
113 Sociodemographic Characteristics of Patients with Multiple Sclerosis Disease in Morocco. Lotfi, Rachid

59 C p.
artikel
114 S1P receptor modulators in Multiple Sclerosis: Detecting a potential skin cancer safety signal Stamatellos, Vasileios-Periklis

59 C p.
artikel
115 Systematic review and meta-analysis of Mycobacterium avium subsp. paratuberculosis as environmental trigger of multiple sclerosis Ekundayo, Temitope C.

59 C p.
artikel
116 Teaching case in MS differential diagnosis: A Longstanding diagnosis of MS with severe disability Solomon, Andrew J.

59 C p.
artikel
117 Telemedicine and Multiple Sclerosis Management in the Era of COVID-19, Al-Azhar Experience Essmat, Ahmed

59 C p.
artikel
118 The Effect of Disease Modifying Drugs of Multiple Sclerosis on the Effectiveness of BBIBP-CorV COVID19 Vaccine Ghaffari, Mehran

59 C p.
artikel
119 The Effect of Rituximab on Mood Disorders in Multiple Sclerosis Poursadeghfard, Maryam

59 C p.
artikel
120 The Effect of Seasonal Variation on Relapse Rate in Patients with Relapsing-Remitting Multiple Sclerosis in Saudi Arabia Makkawi, Seraj

59 C p.
artikel
121 The elimination of circulating Epstein-Barr virus infected B cells underlies anti-CD20 monoclonal antibody activity in multiple sclerosis: A hypothesis Berger, Joseph R.

59 C p.
artikel
122 The Psychological Effect of COVID19 Pandemic on Neuromyelitis Optica Spectrum Disorder Patients and Their Attitude Change After a Year of the Pandemic in Isfahan, Iran. Dastjerdi, Roshanak Mehdipour

59 C p.
artikel
123 The Relationship Between Smoking and Multiple Sclerosis Severity in Saudi Arabia Makkawi, Seraj

59 C p.
artikel
124 Thermal dysregulation in patients with multiple sclerosis during SARS-CoV-2 infection. The potential therapeutic role of exercise Razi, Omid

59 C p.
artikel
125 The Role of Gut Microbiata in Multiple Sclerosis Zahka, Caesar

59 C p.
artikel
126 To the editors: Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England Tugemann, Bastian

59 C p.
artikel
127 Trait mindfulness, emotion dysregulation, and depression in individuals with multiple sclerosis Duraney, Elizabeth Jean

59 C p.
artikel
128 Trends in administrative prevalence of multiple sclerosis and utilization patterns of disease modifying drugs in Germany Holstiege, Jakob

59 C p.
artikel
129 Two-dimensional measurements with cut-off values are useful for assessing brain volume, physical disability, and processing speed in multiple sclerosis Nishizawa, Kouichi

59 C p.
artikel
130 Type of serum collection tube does not impact neurofilament light chain levels Sotirchos, Elias S.

59 C p.
artikel
131 Uncovering patterns of real-world psychological support seeking and the patient experience in multiple sclerosis Morris-Bankole, Hannah

59 C p.
artikel
132 Urine neopterin in childhood acute demyelinating diseases: Potential for differential diagnosis Kayaoğlu, Meltem Yıldız

59 C p.
artikel
133 Using myelin water imaging to link underlying pathology to clinical function in multiple sclerosis: A scoping review Edwards, Erin M.

59 C p.
artikel
134 Validation of the Norma Latina neuropsychological assessment battery in individuals with multiple sclerosis in Mexico Rivera, Diego

59 C p.
artikel
135 Variability of objective gait measures across the expanded disability status scale in people living with multiple sclerosis: A cross-sectional retrospective analysis Zanotto, Tobia

59 C p.
artikel
136 Variables Affecting Disease Modifying Therapy Adherence and Impact of Adherence on Multiple Sclerosis Patients (Egyptian Experience) Abdelsalam, Amr

59 C p.
artikel
137 Vitamin D3 Improves Behavioral Dysfunction and Promotes Remyelination in Multiple Sclerosis Model Induced by Cuprizone Al-Otaibi, Kholoud M.

59 C p.
artikel
138 Water-Pipe and Cigarette Smoking, Drug Abuse and Alcohol Consumption and the Risk of Primary Progressive Multiple Sclerosis: A Population Based Case-Control Study Eskandarieh, Sharareh

59 C p.
artikel
139 Wilcoxon-Mann-Whitney odds ratio: A statistical measure for ordinal outcomes such as EDSS Howard, C.W.

59 C p.
artikel
                             139 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland